CFO sold ~$313K of Gilead Sciences
Scheduled in advanceLoading…
Traded Oct 28, 2025 · Filed Oct 29, 2025
The boss of Gilead Sciences sold $240K of Gilead Sciences shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$240,259
Shares × reported transaction price
82 days after results of Aug 7, 2025, 2 days before results of Oct 30, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $117.88 on Oct 28, 2025, 34% above its 52-week low and 5% below its high, after a 6% rise over the previous 30 trading days
52-week range $87.75 (Nov 19, 2024) to $124.08 (Oct 21, 2025), 83% of the way up, from 250 adjusted closes. 30 trading days earlier: $110.86 on Sep 16, 2025. Describes the past only, not a forecast
A WARN layoff notice covering 17 workers was filed in California on November 12, 2025.
From the official state WARN list, 15 days after the trade. Shown for timing only; the two filings are separate
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.2% | −1.4% | +5.6% |
| 30 days | +5.0% | +0.1% | +4.9% |
| 90 days | +18.0% | +2.3% | +15.7% |
| 180 days | +9.1% | +4.7% | +4.5% |
Past results only. Not a forecast.
CFO sold ~$313K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Officer sold ~$3.21M of Gilead Sciences
Scheduled in advance